TITLE

绝经后骨质疏松运动疗法的研究进展

AUTHOR(S)
卜淑敏; 韩天雨; 郭盖; 许澳; 孔令华
PUB. DATE
June 2016
SOURCE
Progress in Modern Biomedicine;Jun2016, Vol. 16 Issue 18, p3586
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Postmenopausal osteoporosis is a chronic bone disease occurred in postmenopausal women. At present the treatment of postmenopausal osteoporosis is mainly dependent on drugs, but the patients do not want to use drugs owing to the side effects of drug treatment. So the prevention and treatment of postmenopausal osteoporosis still has challenge and is becoming a public health problem.Exercise is an effective method on prevention and treatment of postmenopausal osteoporosis and is commonly used by doctors and patients in recent years owing to its fewer side effects. This review summarized the current research status of aerobic exercise, resistance exercise, balance and proprioceptive exercise, vibration training, and aquatic exercise on postmenopausal osteoporosis.
ACCESSION #
118031493

 

Related Articles

  • CODING FOR BONE DISEASES.  // For the Record (Great Valley Publishing Company, Inc.);5/9/2011, Vol. 23 Issue 9, p27 

    The article presents the medical coding for bone disease, any condition that affects the skeletal system and can range from very serious to chronic conditions that may cause limited range of motion, deformity or pain. It mentions the several types of osteoporosis, the most common bone disease,...

  • Bisphosphonates and Chronic Kidney Disease. Andersen, Matthew; Kukreja, Subhash // Kidney;May/Jun2008, Vol. 17 Issue 3, p119 

    The article presents a medical study on the pathogenesis of chronic kidney disease (CKD) and the effectiveness of bisphosphonates. It discusses the association of bone disease, renal osteodystrophy (ROD), and postmenopausal osteoporosis (PMO) to CKD population. The medication of biphosphonates...

  • Recognition and Treatment of Postmenopausal Osteoporosis. Hannafon, Freda; Cadogan, Mary P. // Journal of Gerontological Nursing;Mar2014, Vol. 40 Issue 3, p10 

    Osteoporosis is a common but often silent condition among older adults. The characteristic pathological changes associated with osteoporosis may go unnoticed until a fracture occurs or a bone density test is performed. Although osteoporosis occurs in men and among premenopausal women, it is most...

  • Emerging and future therapies for the treatment of bone loss associated with chronic inflammation. Haynes, D. R. // Inflammopharmacology;Dec2006, Vol. 14 Issue 5/6, p193 

    Currently there are many emerging therapies for the treatment of chronic osteoporosis. This is a major problem world wide and particularly of concern in post-menopausal women. This has offered a large expanding market for the pharmaceutical industry and consequently large amounts of money and...

  • How Often Should Healthy Women Be Screened for Osteoporosis? Micks, Elizabeth; Edelman, Alison // OB/GYN Clinical Alert;Apr2012, Vol. 28 Issue 4, p94 

    The article presents information related to a study conducted to determine the development of osteoporosis in post-menopausal women. It is mentioned that study has been performed on 5000 post-menopausal women. It is discussed that 10 percent of women having normal bone mineral density requires...

  • Lycopene & bone health. Rao, Leticia G. // Alive: Canada's Natural Health & Wellness Magazine;Aug2008, Issue 310, p94 

    The article discusses the benefits of lycopene, an antioxidant found in tomatoes and tomato products, in the prevention of bone loss and osteoporosis. According to a research, women taking food high in lycopene have lower oxidative stress parameters and lower bone turnover markers. Oxidative...

  • COLLAGEN CROSSLINKED N-TELOPEPTIDE  // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2006, p395 

    Osteoporosis is the most common bone disease in the West. It is often called the “silent disease” because bone loss occurs without symptoms. The formation and maintenance of bone mass is dependent on a combination of factors that include genetics, nutrition, exercise, and hormone...

  • Management of osteoporosis in patients with chronic kidney disease. Gupta, Abhaya // British Journal of Hospital Medicine (17508460);Feb2014, Vol. 75 Issue 2, p83 

    The article indicates that osteoporosis and chronic kidney disease are common in old age and often occur together, with both diseases leading to increased bone fragility and fractures. It examines the challenges in diagnosis, evaluation, and management of osteoporosis in patients with chronic...

  • SELECTIVE ESTROGEN RECEPTOR MODULATOR CIMICIFUGA RACIMOSA IN TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL CHRONIC RENAL DISEASE WOMEN.  // Osteoporosis International;Mar2006 Supplement 1, Vol. 17, pS23 

    The article presents the abstract of the research "Selective Estrogen Receptor Modulator Cimicifuga Racimosa in Treatment of Osteoporosis in Postmenopausal Chronic Renal Disease Women."

  • Osteoporosis in inflammatory bowel disease. Compston, J. // Gut;Jan2003, Vol. 52 Issue 1, p63 

    Reports on inflammatory bowel disease (IBD) which is associated with an increased prevalence of osteoporosis, a condition characterized by reduced bone mineral density and increased risk of fragility fracture. Therapeutic interventions that reduce fracture risk in postmenopausal women with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics